US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 18.860
  • -0.060-0.32%
Close Oct 31 16:00 ET
  • 19.350
  • +0.490+2.60%
Post 18:25 ET
1.60BMarket Cap-5547P/E (TTM)

Syndax Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
3.5M
0
0
0
0
0
0
0
0
0
Operating revenue
--3.5M
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
56.44%77.72M
72.80%79.51M
51.53%229.95M
85.34%77.91M
60.37%56.36M
31.69%49.68M
24.84%46.02M
33.72%151.76M
36.35%42.03M
8.44%35.14M
Selling and administrative expenses
94.86%29.06M
92.48%23.02M
101.22%66.92M
123.50%22.78M
109.56%17.27M
86.66%14.91M
74.97%11.96M
31.76%33.26M
47.13%10.19M
21.16%8.24M
-General and administrative expense
94.86%29.06M
92.48%23.02M
----
----
109.56%17.27M
86.66%14.91M
74.97%11.96M
----
----
21.16%8.24M
Research and development costs
39.96%48.66M
65.89%56.49M
37.58%163.03M
73.13%55.13M
45.30%39.09M
16.92%34.76M
13.43%34.05M
34.28%118.5M
33.23%31.84M
5.06%26.9M
Operating profit
-49.39%-74.22M
-72.80%-79.51M
-51.53%-229.95M
-85.34%-77.91M
-60.37%-56.36M
-31.69%-49.68M
-24.84%-46.02M
-678.78%-151.76M
-143.90%-42.03M
-75.42%-35.14M
Net non-operating interest income expense
21.00%6.24M
42.99%7.2M
666.18%20.96M
86.32%5.49M
15,884.85%5.28M
2,717.49%5.16M
1,279.39%5.04M
282.82%2.74M
2,905.10%2.95M
105.83%33K
Non-operating interest income
21.06%6.28M
42.95%7.26M
260.41%21.16M
85.74%5.55M
200.11%5.35M
491.23%5.19M
2,166.07%5.08M
1,357.07%5.87M
3,183.52%2.99M
2,045.78%1.78M
Non-operating interest expense
28.57%45K
37.50%55K
-93.37%208K
46.51%63K
-96.00%70K
-94.96%35K
-93.86%40K
65.19%3.14M
714.29%43K
169.34%1.75M
Other net income (expense)
7.53%-86K
40.82%-87K
-14.24%-361K
48.11%-55K
77.63%-66K
-200.00%-93K
-226.72%-147K
-256.44%-316K
-130.20%-106K
-619.51%-295K
Other non- operating income (expenses)
7.53%-86K
40.82%-87K
-14.24%-361K
48.11%-55K
77.63%-66K
-200.00%-93K
-226.72%-147K
-256.44%-316K
-130.20%-106K
-619.51%-295K
Income before tax
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
-71.53%-35.4M
Income tax
Net income
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
-71.53%-35.4M
Net income continuous Operations
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
-71.53%-35.4M
Minority interest income
Net income attributable to the parent company
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
-71.53%-35.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
-71.53%-35.4M
Basic earnings per share
-25.00%-0.8
-44.07%-0.85
-21.14%-2.98
-61.29%-1
-25.86%-0.73
-3.23%-0.64
6.35%-0.59
-612.50%-2.46
-134.25%-0.62
-45.00%-0.58
Diluted earnings per share
-25.00%-0.8
-44.07%-0.85
-21.14%-2.98
-61.29%-1
-25.86%-0.73
-3.23%-0.64
6.35%-0.59
-634.78%-2.46
-134.25%-0.62
-45.00%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 3.5M000000000
Operating revenue --3.5M--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 56.44%77.72M72.80%79.51M51.53%229.95M85.34%77.91M60.37%56.36M31.69%49.68M24.84%46.02M33.72%151.76M36.35%42.03M8.44%35.14M
Selling and administrative expenses 94.86%29.06M92.48%23.02M101.22%66.92M123.50%22.78M109.56%17.27M86.66%14.91M74.97%11.96M31.76%33.26M47.13%10.19M21.16%8.24M
-General and administrative expense 94.86%29.06M92.48%23.02M--------109.56%17.27M86.66%14.91M74.97%11.96M--------21.16%8.24M
Research and development costs 39.96%48.66M65.89%56.49M37.58%163.03M73.13%55.13M45.30%39.09M16.92%34.76M13.43%34.05M34.28%118.5M33.23%31.84M5.06%26.9M
Operating profit -49.39%-74.22M-72.80%-79.51M-51.53%-229.95M-85.34%-77.91M-60.37%-56.36M-31.69%-49.68M-24.84%-46.02M-678.78%-151.76M-143.90%-42.03M-75.42%-35.14M
Net non-operating interest income expense 21.00%6.24M42.99%7.2M666.18%20.96M86.32%5.49M15,884.85%5.28M2,717.49%5.16M1,279.39%5.04M282.82%2.74M2,905.10%2.95M105.83%33K
Non-operating interest income 21.06%6.28M42.95%7.26M260.41%21.16M85.74%5.55M200.11%5.35M491.23%5.19M2,166.07%5.08M1,357.07%5.87M3,183.52%2.99M2,045.78%1.78M
Non-operating interest expense 28.57%45K37.50%55K-93.37%208K46.51%63K-96.00%70K-94.96%35K-93.86%40K65.19%3.14M714.29%43K169.34%1.75M
Other net income (expense) 7.53%-86K40.82%-87K-14.24%-361K48.11%-55K77.63%-66K-200.00%-93K-226.72%-147K-256.44%-316K-130.20%-106K-619.51%-295K
Other non- operating income (expenses) 7.53%-86K40.82%-87K-14.24%-361K48.11%-55K77.63%-66K-200.00%-93K-226.72%-147K-256.44%-316K-130.20%-106K-619.51%-295K
Income before tax -52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M-71.53%-35.4M
Income tax
Net income -52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M-71.53%-35.4M
Net income continuous Operations -52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M-71.53%-35.4M
Minority interest income
Net income attributable to the parent company -52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M-71.53%-35.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M-71.53%-35.4M
Basic earnings per share -25.00%-0.8-44.07%-0.85-21.14%-2.98-61.29%-1-25.86%-0.73-3.23%-0.646.35%-0.59-612.50%-2.46-134.25%-0.62-45.00%-0.58
Diluted earnings per share -25.00%-0.8-44.07%-0.85-21.14%-2.98-61.29%-1-25.86%-0.73-3.23%-0.646.35%-0.59-634.78%-2.46-134.25%-0.62-45.00%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data